The article discusses the rising use of GLP-1 weight loss drugs in children to combat obesity and Type 2 diabetes, highlighting both the promising short-term health benefits and ethical concerns surrounding their use, while emphasizing that reliance on medication is insufficient without addressing the underlying issues of unhealthy food environments contributing to the obesity crisis. #ChildhoodObesity #HealthPolicy #ChronicIllness #USA
www.nytimes.com
Opinion | If Kids Need GLP-1s, We've Already Let Them Down
Ms. Belluz is a contributing Opinion writer covering health, nutrition and chronic illness.
When Dr. Aaron Kelly began studying the effects of GLP-1 weight loss drugs in children with obesity, he thought it would be difficult to recruit patients.